| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.036 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0089 | 0.9 |